James Leavitt, MD
Gastroenterology · Miami, FLNPI 1598740557
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.5%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 20.3%. Reporting peaked in 2024 at $4,922 and has fallen 73.6% since, to $1,298 in 2025. Among gastroenterology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $61.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Echosens North America, Inc.$4K
- Pentax Of America, Inc.$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
- E.r. Squibb & Sons, L.L.C.$2K
- AbbVie$2K
- Johnson & Johnson$1K
- plus $4K from 33 others
Across 67 payments — averaging $8775.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$575K
- Teva Pharmaceuticals USA, Inc.$13K
What the payments were for
- Consulting fees$4,10123%
- Speaking & faculty fees$6,10034%
- Food & beverage$7,52642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FibroScan$3,600
- XIFAXAN$2,500
- PENTAX Medical$1,163
- STELARA$777
- INSPIRA$582
- C2 CryoBalloon Focal Controller$582
- C2 Cryoballoon$582
- GI Genius$322
- Skyrizi$260
- APOLLO ESG System$150
- IMAGINA$145
- Sucraid$131
- ZEPOSIA$125
- Rinvoq$120
- VOQUEZNA$117
- GENERAL - THERAPIES$113
- CapsoCam Plus$112
How this compares
$17,726 in reported general payments places this provider in the 90th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 25 | $680,850 |
| RinvoqUpadacitinib | 17 | $184,217 |
| Mesalamine | 54 | $25,025 |
| LinzessLinaclotide | 20 | $19,139 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 57 | $9,285 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 38 | $6,490 |
| Omeprazole | 282 | $5,271 |
| Budesonide EcBudesonide | 18 | $3,830 |
| Mercaptopurine | 14 | $2,226 |
| Pantoprazole Sodium | 75 | $1,418 |
| CholestyramineCholestyramine (With Sugar) | 12 | $1,392 |
| Dicyclomine Hcl | 17 | $605 |
| Esomeprazole Magnesium | 11 | $318 |
| Famotidine | 21 | $274 |
| Prednisone | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $1,031 | $680,85025 claims |
| AbbVieRinvoq, Linzess | $1,576 | $203,35737 claims |
| Braintree Laboratories, Inc.Sutab | $13 | $9,28557 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $17 | $6,49038 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Miami
- Lukasz KwapiszMiami$1.2M
- Joanna LopezMiami$670K
- Jerry MartelMiami$511K
- Andres GelrudMiami$208K
- Maria HernandezMiami$197K
- George SanchezMiami$117K
- Jodie BarkinMiami$101K
- Javier ParraMiami$68K
- Samuel GidayOrlando$2M
- Jennifer Seminerio-DiehlOrlando$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.